Andrianov AM - Search Results

1

Metabolomic profiling of three Araucaria species, and their possible potential role against COVID-19.

El-Hawary SS, Rabeh MA, Raey MAE, El-Kadder EMA, Sobeh M, Abdelmohsen UR, Albohy A, Andrianov AM, Bosko IP, Al-Sanea MM, El-Kolobby DG. El-Hawary SS, et al. Among authors: andrianov am. J Biomol Struct Dyn. 2022 Sep;40(14):6426-6438. doi: 10.1080/07391102.2021.1885494. Epub 2021 Feb 18. J Biomol Struct Dyn. 2022. PMID: 33596787 Free PMC article.

2

Computational discovery of small drug-like compounds as potential inhibitors of SARS-CoV-2 main protease.

Andrianov AM, Kornoushenko YV, Karpenko AD, Bosko IP, Tuzikov AV. Andrianov AM, et al. J Biomol Struct Dyn. 2021 Sep;39(15):5779-5791. doi: 10.1080/07391102.2020.1792989. Epub 2020 Jul 14. J Biomol Struct Dyn. 2021. PMID: 32662333 Free PMC article.

3

Application of deep learning and molecular modeling to identify small drug-like compounds as potential HIV-1 entry inhibitors.

Andrianov AM, Nikolaev GI, Shuldov NA, Bosko IP, Anischenko AI, Tuzikov AV. Andrianov AM, et al. J Biomol Struct Dyn. 2022 Oct;40(16):7555-7573. doi: 10.1080/07391102.2021.1905559. Epub 2021 Apr 15. J Biomol Struct Dyn. 2022. PMID: 33855929

4

In silico design and computational evaluation of novel 2-arylaminopyrimidine-based compounds as potential multi-targeted protein kinase inhibitors: application for the native and mutant (T315I) Bcr-Abl tyrosine kinase.

Koroleva EV, Kornoushenko YV, Karpenko AD, Bosko IP, Siniutsich JV, Ignatovich ZV, Andrianov AM. Koroleva EV, et al. Among authors: andrianov am. J Biomol Struct Dyn. 2023 Jun;41(9):4065-4080. doi: 10.1080/07391102.2022.2062784. Epub 2022 Apr 26. J Biomol Struct Dyn. 2023. PMID: 35470777

5

In silico design of novel broad anti-HIV-1 agents based on glycosphingolipid β-galactosylceramide, a high-affinity receptor for the envelope gp120 V3 loop.

Andrianov AM, Kornoushenko YV, Kashyn IA, Kisel MA, Tuzikov AV. Andrianov AM, et al. J Biomol Struct Dyn. 2015;33(5):1051-66. doi: 10.1080/07391102.2014.926832. Epub 2014 Jun 19. J Biomol Struct Dyn. 2015. PMID: 24942968

6

Discovery of novel anti-HIV-1 agents based on a broadly neutralizing antibody against the envelope gp120 V3 loop: a computational study.

Andrianov AM, Kashyn IA, Tuzikov AV. Andrianov AM, et al. J Biomol Struct Dyn. 2014 Dec;32(12):1993-2004. doi: 10.1080/07391102.2013.848825. Epub 2013 Nov 20. J Biomol Struct Dyn. 2014. PMID: 24251545

7

Computational model of the HIV-1 subtype A V3 loop: study on the conformational mobility for structure-based anti-AIDS drug design.

Andrianov AM, Anishchenko IV. Andrianov AM, et al. J Biomol Struct Dyn. 2009 Oct;27(2):179-93. doi: 10.1080/07391102.2009.10507308. J Biomol Struct Dyn. 2009. PMID: 19583444

8

Immunophilins and HIV-1 V3 loop for structure-based anti-AIDS drug design.

Andrianov AM. Andrianov AM. J Biomol Struct Dyn. 2009 Feb;26(4):445-54. doi: 10.1080/07391102.2009.10507259. J Biomol Struct Dyn. 2009. PMID: 19108583

9

Structural analysis of the envelope gp120 V3 loop for some HIV-1 variants circulating in the countries of Eastern Europe.

Andrianov AM, Kornoushenko YV, Anishchenko IV, Eremin VF, Tuzikov AV. Andrianov AM, et al. J Biomol Struct Dyn. 2013;31(7):665-83. doi: 10.1080/07391102.2012.706455. Epub 2012 Aug 13. J Biomol Struct Dyn. 2013. PMID: 22888999

10

Computational anti-AIDS drug design based on the analysis of the specific interactions between immunophilins and the HIV-1 gp120 V3 loop. Application to the FK506-binding protein.

Andrianov AM. Andrianov AM. J Biomol Struct Dyn. 2008 Aug;26(1):49-56. doi: 10.1080/07391102.2008.10507222. J Biomol Struct Dyn. 2008. PMID: 18533725

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

62 results

Search Page